Brief: Aprea Therapeutics Reports Fourth Quarter Loss Per Share Of $0.36
15/03/2022 21:06
March 15 (Reuters) - Aprea Therapeutics Inc APRE.O :
* APREA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND PROVIDES UPDATE ON BUSINESS OPERATIONS
* Q4 LOSS PER SHARE $0.36
* BELIEVES CASH, CASH EQUIVALENTS AS OF DEC 31, 2021
SUFFICIENT TO
MEET ITS CURRENT PROJECTED OPERATING REQUIREMENTS INTO 2023
Source text for Eikon: ID:nGNX9nhwT6
Further company coverage: APRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aprea Therapeutics
See all newsAprea Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aprea Therapeutics Q2 net loss widens on higher R&D costs
Aprea Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Aprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026
Brief: Aprea Therapeutics - Files For Resale Of Up To 5.5 Million Shares By Selling Stockholders - SEC Filing